Friday, May 24, 2024 May 24, 2024
77° F Dallas, TX
Partner Content i This advertising content was produced in collaboration between D Magazine and our sponsor, without involvement from D Magazine editorial staff.

Face of Cancer Care

Steven Paulson, M.D., Texas Oncology
| |Photography by Bret Redman
Photography by Bret Redman

According to the American Cancer Society, more than 130,000 new cases of cancer are expected to be diagnosed in Texas in 2024, which ranks third in the nation for most new cancer cases and third in expected cancer deaths.

Despite these numbers, the medical community is making great strides in the treatment of cancer as a result of providing patients with more options. These improvements run the full gamut from a better understanding of prevention and improved early detection methods, more effective chemotherapy medicines and radiation tools, and faster and more precise treatment options such as targeted therapies and immunotherapy. 

A pioneer in community-based cancer care, Texas Oncology’s mission is to provide high-quality cancer care and leading-edge technology and therapy options to patients where they live, without leaving home and the critical support of family and friends.  

A commitment to quality cancer treatment is tailored to patient needs, including medical oncology, radiation oncology, hematology, imaging services (X-rays, PET, CT), laboratory, and pharmacy services. In addition, patients have access to numerous other services that can enhance and facilitate their medical care, such as pain management, palliative medicine, nutrition counseling, social services, and financial counseling. 

A wide scope of subspecialities provide a broad range of services including neuro-oncology, blood and marrow transplant, colon and rectal surgery, genitourinary oncology, gynecologic oncology, hematology, orthopedic oncology, pediatric oncology, and breast surgery. Evidence-based and value-based care models focus on overall value and patient outcomes, significantly improving how cancer care is managed.

Patients have the opportunity to participate in some of the most promising national clinical trials for a broad range of cancers. Texas Oncology’s robust community-based clinical trials and research program has helped develop more than 100 FDA-approved cancer therapies. At any given time, more than 150 national clinical trials are open throughout the network.

With more than 530 physicians and more than 280 sites of service, Texas Oncology offers comprehensive, multidisciplinary care combined with the power and resources of an outstanding network to more than 71,000 new patients fighting cancer yearly. 

888.864.4226 |